Is Humira (adalimumab) used for Crohn’s disease?
Humira, which is adalimumab, is used to treat Crohn’s disease. It works by blocking tumor necrosis factor (TNF), a protein involved in inflammation. This TNF-blocking action helps reduce Crohn’s symptoms and intestinal inflammation. [1]
What Crohn’s situations does Humira cover (flare vs maintenance)?
For Crohn’s disease, Humira is used for both:
- Induction (to bring symptoms under control during active disease)
- Maintenance (to help keep the disease controlled over time) [1]
How is Humira given for Crohn’s?
Humira is typically given by injection. The exact dosing schedule for Crohn’s can vary depending on the clinical scenario (for example, whether it is induction or maintenance and how the dose is adjusted by the treating clinician). [1]
Who should not use Humira, and what safety issues matter in Crohn’s?
TNF inhibitors can increase the risk of certain infections, so screening and monitoring are important before and during treatment. Humira may also be avoided or used with extra caution in people with specific serious infections or other high-risk medical situations. [1]
Common patient concerns when starting Humira for Crohn’s include infection risk and what to watch for while on therapy; clinicians typically screen for tuberculosis and assess infection history before treatment begins. [1]
What happens if Humira doesn’t work or stops working?
If symptoms do not improve, or if the response fades over time, doctors may adjust the treatment plan. Options can include dose adjustments or switching to another therapy for Crohn’s, depending on why it failed (for example, lack of response versus loss of response). [1]
How does Humira compare with other biologics for Crohn’s?
Humira is one of several biologic options used in Crohn’s disease. Other biologics target different inflammatory pathways (not TNF directly). Choice often depends on disease pattern, prior treatments, risk profile, access, and response to therapy. [1]
Are there biosimilars for Humira?
Biosimilars are available for some adalimumab products in many markets, and they can offer an alternative to brand-name Humira depending on availability and local prescribing rules. [1]
Sources
[1] https://www.humira.com/